The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Synthetic Glucocorticoids That Dissociate Transactivation and AP-1 Transrepression Exhibit Antiinflammatory Activity in Vivo
Open accessAbstract
Some of the most potent antiinflammatory and immunosuppressive agents are synthetic glucocorticoids. However, major side effects severely limit their therapeutic use. The development of improved glucocorticoid-based drugs will require the separation of beneficial from deleterious effects. One possibility toward this goal is to try to dissociate two main activities of glucocorticoids, i.e. transactivation and transrepression. Screening of a library of compounds using transactivation and AP-1 transrepression models in transiently transfected cells identified dissociated glucocorticoids, which exert strong AP-1 inhibition but little or no transactivation. Importantly, despite high ligand binding affinity, the prototypic dissociated compound, RU24858, acted as a weak agonist and did not efficiently antagonize dexamethasone-induced transcription in transfected cells. Similar results were obtained in hepatic HTC cells for the transactivation of the endogenous tyrosine amino transferase gene (TAT), which encodes one of the enzymes involved in the glucocorticoid-dependent stimulation of neoglucogenesis. To investigate whether dissociated glucocorticoids retained the antiinflammatory and immunosuppressive potential of classic glucocorticoids, several in vitro and in vivo models were used. Indeed, secretion of the proinflammatory lymphokine interleukin-1beta was severely inhibited by dissociated glucocorticoids in human monocytic THP 1 cells. Moreover, in two in vivo models, these compounds exerted an antiinflammatory and immunosuppressive activity as potent as that of the classic glucocorticoid prednisolone. These results may lead to an improvement of antiinflammatory and immunosuppressive therapies and provide a novel concept for drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,387
Steroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,823
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Jonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Diamond, M. I., Miner, J. N., Yoshinaga, S. K., & Yamamoto, K. R. (1990) · Science · doi:10.1126/science.2119054 · Cited by 1,292
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
Schüle, R., Rangarajan, P., Kliewer, S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., & Evans, R. M. (1990) · Cell · doi:10.1016/0092-8674(90)90397-w · Cited by 1,221
Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P., & Gronemeyer, H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00736.x · Cited by 1,079
Self-citationRay, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life?
Kastner, P., Mark, M., & Chambon, P. (1995) · Cell · doi:10.1016/0092-8674(95)90202-3 · Cited by 995
Science in Pictures: Chaos and Fractals in Human Physiology
Goldberger, A. L., Rigney, D. R., & West, B. J. (1990) · Scientific American · doi:10.1038/scientificamerican0290-42 · Cited by 803
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00007 · Cited by 778
Berry, M., Metzger, D., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07469.x · Cited by 767
Diamondstone, T. I. (1966) · Analytical Biochemistry · doi:10.1016/0003-2697(66)90220-x · Cited by 758
Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.
Cavaillès, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P. J., & Parker, M. G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00044.x · Cited by 751
Jantzen, H.-M., Strähle, U., Gloss, B., Stewart, F., Schmid, W., Boshart, M., Miksicek, R., & Schütz, G. (1987) · Cell · doi:10.1016/0092-8674(87)90752-5 · Cited by 724
Biological properties of interleukin 10
Howard, M., & O'Garra, A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90153-x · Cited by 640
Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription
Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C., & Brown, M. (1994) · Science · doi:10.1126/science.8197458 · Cited by 637
Le Douarin, B., Zechel, C., Garnier, J. M., Lutz, Y., Tora, L., Pierrat, P., Heery, D., Gronemeyer, H., Chambon, P., & Losson, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07194.x · Cited by 619
Self-citationWEBSTER, N. (1988) · Cell · doi:10.1016/0092-8674(88)90552-1 · Cited by 580
Steroid hormone receptors compete for factors that mediate their enhancer function
Meyer, M.-E., Gronemeyer, H., Turcotte, B., Bocquel, M.-T., Tasset, D., & Chambon, P. (1989) · Cell · doi:10.1016/0092-8674(89)90918-5 · Cited by 566
Self-citationHeck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P., & Cato, A. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06726.x · Cited by 522
Lee, S. W., Tsou, A. P., Chan, H., Thomas, J., Petrie, K., Eugui, E. M., & Allison, A. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1204 · Cited by 506
Caldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Gustafsson, J. A., & Van der Saag, P. T. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.4.7659084 · Cited by 489
Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
Baulieu, E.-E. (1989) · Science · doi:10.1126/science.2781282 · Cited by 483
Negative Regulation by Glucocorticoids Through Interference with a cAMP Responsive Enhancer
Akerblom, I. E., Slater, E. P., Beato, M., Baxter, J. D., & Mellon, P. L. (1988) · Science · doi:10.1126/science.2838908 · Cited by 481
Nuclear Receptor/AP-1 Interaction*
PFAHL, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-5-651 · Cited by 446
Interaction of thyroid-hormone receptor with a conserved transcriptional mediator
Lee, J. W., Ryan, F., Swaffield, J. C., Johnston, S. A., & Moore, D. D. (1995) · Nature · doi:10.1038/374091a0 · Cited by 425
Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T., & Matsushima, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36831-x · Cited by 424
vom Baur, E., Zechel, C., Heery, D., Heine, M. J., Garnier, J. M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P., & Losson, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00339.x · Cited by 399
Self-citationPathway to carrageenan-induced inflammation in the hind limb of the rat.
Vinegar, R., Truax, J. F., Selph, J. L., Johnston, P. R., Venable, A. L., & McKenzie, K. K. (1987) · PubMed · Cited by 392
Bresnick, E. H., Dalman, F. C., Sanchez, E. R., & Pratt, W. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83689-4 · Cited by 384
Knudsen, P. J., Dinarello, C. A., & Strom, T. B. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4129 · Cited by 375
Distinct classes of transcriptional activating domains function by different mechanisms
Tasset, D., Tora, L., Fromental, C., Scheer, E., & Chambon, P. (1990) · Cell · doi:10.1016/0092-8674(90)90394-t · Cited by 357
Transcription factors 3: nuclear receptors.
Gronemeyer, H., & Laudet, V. (1995) · PubMed · Cited by 315
Self-citationA new class of retinoids with selective inhibition of AP-1 inhibits proliferation
Fanjul, A., Dawson, M. I., Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X.-P., & Pfahl, M. (1994) · Nature · doi:10.1038/372107a0 · Cited by 313
Bocquel, M. T., Kumar, V., Stricker, C., Chambon, P., & Gronemeyer, H. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.7.2581 · Cited by 292
Self-citationKönig, H., Ponta, H., Rahmsdorf, H. J., & Herrlich, P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05283.x · Cited by 271
Green, S., Kumar, V., Theulaz, I., Wahli, W., & Chambon, P. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03168.x · Cited by 270
Lucibello, F. C., Slater, E. P., Jooss, K. U., Beato, M., & Müller, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07471.x · Cited by 269
Chen, J. Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E., Reczek, P., Chambon, P., & Gronemeyer, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07102.x · Cited by 255
Self-citationCaldenhoven, E. (1995) · Molecular Endocrinology · doi:10.1210/me.9.4.401 · Cited by 253
Regulation of Cytokine Gene Expression
Taniguchi, T. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.002255 · Cited by 231
Brostjan, C., Anrather, J., Csizmadia, V., Stroka, D., Soares, M., Bach, F. H., & Winkler, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19612 · Cited by 198
Shemshedini, L., Knauthe, R., Sassone-Corsi, P., Pornon, A., & Gronemeyer, H. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04953.x · Cited by 189
Self-citationFos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.
Kerppola, T. K., Luk, D., & Curran, T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3782 · Cited by 168
Separation of Transactivation and AP1 Antagonism Functions of Retinoic Acid Receptor α
Nagpal, S., Athanikar, J., & Chandraratna, R. A. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.923 · Cited by 164
Webster, N. J., Green, S., Tasset, D. M., Ponglikitmongkol, M., & Chambon, P. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03526.x · Cited by 106
Review: Transcriptional and post-transcriptional regulation of interleukin 1 gene expression
Fenton, M. J. (1992) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(92)90170-p · Cited by 104
Pro‐opiomelanocortin gene: A model for negative regulation of transcription by glucocorticoids
Drouin, J., Charron, J., Gagner, J., Jeannotte, L., Nemer, M. J., Plante, R. K., & Wränge, Ö. (1987) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240350404 · Cited by 102
Nemoto, T., Ohara‐Nemoto, Y., Denis, M. G., & Gustafsson, J. A. (1990) · Biochemistry · doi:10.1021/bi00459a031 · Cited by 100
17α-Alkynyl-11β,17-dihydroxyandrostane derivatives : A new class of potent glucocorticoids.
Teutsch, G., COSTEROUSSE, G., Deraedt, R., Benzoni, J., Fortin, M., & Philibert, D. (1981) · Steroids · doi:10.1016/0039-128x(81)90084-2 · Cited by 94
Interleukin-1: a gene expression system regulated at multiple levels.
Auron, P. E., & Webb, A. C. (1994) · PubMed · Cited by 92
(1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90267-a · Cited by 50
On the Mechanism of Action of RU486
Baulieu, É.-É. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb37946.x · Cited by 27
Nishida, T., Takano, M., Kawakami, T., Nishino, N., Nakai, S., & Hirai, Y. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80835-0 · Cited by 23
Chrousos, G. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00099-8 · Cited by 17
Cited by
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
THE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSIS
Kroemer, G., Dallaporta, B., & Resche-Rigon, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.619 · Cited by 1,963
Self-citationNuclear Hormone Receptors and Gene Expression
Aranda, A., & Pascual, A. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1269 · Cited by 1,570
Principles for modulation of the nuclear receptor superfamily
Gronemeyer, H., Gustafsson, J.-Å., & Laudet, V. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1551 · Cited by 1,226
Self-citation
Metadata
- Authors
- Vayssière, B. M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H., & Resche-Rigon, M.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1997-08
- Volume
- 11
- Issue
- 9
- Pages
- 1245-1255
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2004391265
- Cited by
- 311
- References
- 60
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.